Open access · CC-BY
via OpenAlex
Instant stem cell therapy: Characterization and concentration of human mesenchymal stem cells in vitro
Philip Kasten, Ingo Beyen, Marcus Egermann, Arnold J. Suda, AA Moghaddam, Gerald Zimmermann, Reto Luginbühl
European Cells and Materials · 2008 · ▲ 83 citations
Abstract
In regenerative medicine, there is an approach to avoid expansion of the mesenchymal stem cell (MSC) before implantation. The aim of this study was to compare methods for instant MSC therapy by use of a portable, automatic and closed system centrifuge that allows for the concentration of MSCs. The main outcome measures were the amount of MSCs per millilitre of bone marrow (BM), clusters of differentiation (CD), proliferation and differentiation capacities of the MSC. A volume reduction protocol was compared to the traditional laboratory methods of isolation using a Ficoll gradient and native BM. Fifty millilitres of BM were obtained from haematologically healthy male Caucasians (n=10, age 8 to 49 years). The number of colony forming units-fibroblast (CFU-F)/ml BM was highest in the centrifuge volume reduction protocol, followed by the native BM (not significant), the centrifuge Ficoll (p=0.042) and the manual Ficoll procedure (p=0.001). The MSC of all groups could differentiate into the mesenchymal lineages without significant differences between the groups. The CD pattern was identical for all groups: CD13+; CD 44+; CD73 +; CD90+; CD105+; HLA-A,B,C+; CD14-; CD34-; CD45-; CD271-; HLA-DR-. In a further clinical pilot study (n=5) with 297 ml BM (SD 18.6), the volume reduction protocol concentrated the MSC by a factor of 14: there were 1.08 x 10(2) MSC/ml BM (standard deviation (SD) 1.02 x 10(2)) before concentration, 14.8 x 10(2) MSC/ ml BM (SD 12.4 x 10(2)) after concentration, and on average 296 x 10(2) MSC (SD 248.9 x 10(2), range 86.4-691.5 x 10(2)) were available for MSC therapy. The volume reduction protocol of the closed centrifuge allows for the highest concentration of the MSC, and therefore, is a promising candidate for instant stem cell therapy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.22203/ecm.v016a06
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Kasten, P., Beyen, I., Egermann, M., Suda, A.J., Moghaddam, A., Zimmermann, G., & Luginbühl, R. (2008). Instant stem cell therapy: Characterization and concentration of human mesenchymal stem cells in vitro. <em>European Cells and Materials</em>. https://doi.org/10.22203/ecm.v016a06
Vancouver
Kasten P, Beyen I, Egermann M, Suda AJ, Moghaddam A, Zimmermann G, et al. Instant stem cell therapy: Characterization and concentration of human mesenchymal stem cells in vitro. European Cells and Materials. 2008. doi:10.22203/ecm.v016a06.
BibTeX
@article{philip2008Instan,
title = {Instant stem cell therapy: Characterization and concentration of human mesenchymal stem cells in vitro},
author = {Philip Kasten and Ingo Beyen and Marcus Egermann and Arnold J. Suda and AA Moghaddam and Gerald Zimmermann and Reto Luginbühl},
journal = {European Cells and Materials},
year = {2008},
doi = {10.22203/ecm.v016a06},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Health 2011
Citation only
Mesenchymal Stem-Cell-Based Therapy for the Older Patient
Stem cells in clinical applications 2016
Citation only
Mesenchymal Stem Cell Therapy in Rheumatoid Arthritis
Journal of Clinical Orthopaedics and Trauma 2016
Open access · OA
Mesenchymal stem cell therapy for osteoarthritis
Pediatric Research 2008
Citation only
Endothelial Colony Forming Cells and Mesenchymal Stem Cells are Enriched at Different Gestational Ages in Human Umbilical Cord Blood
Cell Proliferation 2019
Open access · CC-BY
MicroRNA‐130a controls bone marrow mesenchymal stem cell differentiation towards the osteoblastic and adipogenic fate
Stem Cell Research 2008
Open access · OA